GainersToday.com
GainersToday.com, Tracking Stock Market Picks
Enter Symbol:
 
Idenix Pharmaceuticals, Inc. (IDIX) [hlAlert]

Rating:
Sell IDIX
down 49.83 %

Idenix Pharmaceuticals, Inc. (IDIX) downgraded to Sell with price target $2 by ThinkEquity

Posted on: Thursday,  Feb 10, 2011  8:25 AM ET by ThinkEquity

ThinkEquity rated Sell Idenix Pharmaceuticals, Inc. (NASDAQ: IDIX) on 02/10/2011. Previously ThinkEquity rated Accumulate Idenix Pharmaceuticals, Inc. (NASDAQ: IDIX) on 01/27/2009.,
when the stock price was $5.98. Since then, Idenix Pharmaceuticals, Inc. has lost 49.83% as of 02/10/2011's recent price of $3.00.
If you would have followed the previous ThinkEquity's recommendation on IDIX, you would have lost 49.83% of your investment in 744 days.

Idenix Pharmaceuticals, Inc. is a biopharmaceutical company engaged in the discovery and development of drugs for the treatment of human viral and other infectious diseases. Idenix's current focus is on the treatment of infections caused by hepatitis B virus, hepatitis C virus and human immunodeficiency virus.

Research is at the core of everything we do at ThinkEquity, and we're passionate about it. Employing a disciplined and rigorous process, we scrutinize the spectrum of forces at play in the growth sectors we cover. Starting with a top down analysis, we look closely at the megatrends and industry drivers that create opportunities for innovative companies. We then allocate our resources based on a long-range research roadmap that leads to deep domain expertise and a close working knowledge of the technologies, products, services and people that populate the growth sector landscape. In short, the sum result of the ThinkEquity research process is to identify and affiliate ourselves with the fastest growing private and public companies within our domain verticals.
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
2/10/2011 8:25 AM Sell
None
3.00 2.00
as of 12/30/2011
1 Week up  4.11 %
1 Month up  1.97 %
3 Months down  -49.29 %
1 YTD down  -188.80 %
Previous Recommendations
Date/Time (ET)SymbolRatingTermPrice (*)Target
1/27/2009 8:25 AM Buy
None
5.98 6.00

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy